Global Information
회사소개 | 문의 | 위시리스트

미국의 체외진단(IVD) 시장 : 부문별, 제품별, 기업별 예측

United States In Vitro Diagnostics Market, Forecast by IVD Segments, Products, Companies

리서치사 Renub Research
발행일 2019년 04월 상품 코드 825610
페이지 정보 영문 225 Pages
가격
US $ 1,995 ₩ 2,372,000 Unprintable PDF by E-mail (Single User License)
US $ 2,495 ₩ 2,967,000 PDF by E-mail (5 User License)
US $ 2,495 ₩ 2,967,000 Unprintable PDF and Hard Copy
US $ 2,995 ₩ 3,562,000 PDF by E-mail (Global Site License)

주의 : 본 보고서는 PDF 파일 이용 시 라이선스에 따라 보고서 인쇄가 제한됩니다.
Single User License 구입 시에는 인쇄가 불가능하므로 이용에 주의하시기 바랍니다.



미국의 체외진단(IVD) 시장 : 부문별, 제품별, 기업별 예측 United States In Vitro Diagnostics Market, Forecast by IVD Segments, Products, Companies
발행일 : 2019년 04월 페이지 정보 : 영문 225 Pages

미국의 체외진단(IVD : In Vitro Diagnostics) 시장에 대해 조사했으며, 시장 동향과 부문별 동향, 지역별 예측, 시장에 참여하는 기업 개요에 대해 정리했습니다.

제1장 서론

제2장 조사 방법

제3장 체외진단(IVD) 시장

제4장 시장 점유율

  • 부문별
  • 제품별
  • 지역별

제5장 부문별 시장

  • 임상화학
  • 미생물학
  • Point of Care(POC)
  • 면역측정
  • 요검사
  • 응고
  • 조직학
  • 혈액학
  • 혈액검사, 혈액형 검사
  • 유세포 분석

제6장 제품별 시장

  • 서비스
  • 소프트웨어
  • 시약
  • 계기

제7장 지역별 시장

  • 남부
  • 서부
  • 중서부
  • 북동부

제8장 시장 역학

  • 성장 촉진요인
    • 만성질환, 감염증 증가
    • 기술 진보
    • 고령화
  • 과제
    • 번거로운 상환 절차
    • 연구실 기술자의 부족

제9장 기업 분석

  • Roche Diagnostics
  • Abbott Diagnostics
  • Siemens Healthineers
  • Danaher Corporation
  • Thermo Fisher Scientific
  • Sysmex Corporation
KSM 19.05.09

List of Figures:

  • Figure-01: United States IVD Market (Million US$), 2013 - 2018
  • Figure-02: Forecast for United States IVD Market (Million US$), 2019 - 2024
  • Figure-03: United States In-Vitro Diagnostics (IVD) Market Share (%) by Segments, 2013 - 2018
  • Figure-04: Forecast for United States In-Vitro Diagnostics (IVD) Market Share (%) by Segments, 2019 - 2024
  • Figure-05: United States In-Vitro Diagnostics (IVD) Market Share (%) by Products, 2013 - 2018
  • Figure-06: Forecast for United States In-Vitro Diagnostics (IVD) Market Share (%) by Products, 2019 - 2024
  • Figure-07: United States In-Vitro Diagnostics (IVD) Market Share (%) by Regions, 2019 - 2024
  • Figure-08: Forecast for Delivery Models - India Online Food Delivery Market Share (%) 2019 - 2023
  • Figure-09: United States - In-Vitro Diagnostics Market by Clinical Chemistry (Million US$), 2013 - 2018
  • Figure-10: United States - Forecast for In-Vitro Diagnostics Market by Clinical Chemistry (Million US$), 2019 - 2024
  • Figure-11: United States - In-Vitro Diagnostics Market by Microbiology -ID/AST (Million US$), 2013 - 2018
  • Figure-12: United States - Forecast for In-Vitro Diagnostics Market by Microbiology -ID/AST (Million US$), 2019 - 2024
  • Figure-13: United States - In-Vitro Diagnostics Market by Microbiology - Molecular (Million US$), 2013 - 2018
  • Figure-14: United States - Forecast for In-Vitro Diagnostics Market by Microbiology - Molecular (Million US$), 2019 - 2024
  • Figure-15: United States - In-Vitro Diagnostics Market by POC - Professional (Million US$), 2013 - 2018
  • Figure-16: United States - Forecast for In-Vitro Diagnostics Market by POC - Professional (Million US$), 2019 - 2024
  • Figure-17: United States - In-Vitro Diagnostics Market by POC - OTC Diabetes (Million US$), 2013 - 2018
  • Figure-18: United States - Forecast for In-Vitro Diagnostics Market by POC - OTC Diabetes (Million US$), 2019 - 2024
  • Figure-19: United States - In-Vitro Diagnostics Market by POC - Others (Million US$), 2013 - 2018
  • Figure-20: United States - Forecast for In-Vitro Diagnostics Market by POC - Others (Million US$), 2019 - 2024
  • Figure-21: United States - In-Vitro Diagnostics Market by Immunoassay - Infectious (Million US$), 2013 - 2018
  • Figure-22: United States - Forecast for In-Vitro Diagnostics Market by Immunoassay - Infectious (Million US$), 2019 - 2024
  • Figure-23: United States - In-Vitro Diagnostics Market by Immunoassay - Others (Million US$), 2013 - 2018
  • Figure-24: United States - Forecast for In-Vitro Diagnostics Market by Immunoassay - Others (Million US$), 2019 - 2024
  • Figure-25: United States - In-Vitro Diagnostics Market by Urinalysis (Million US$), 2013 - 2018
  • Figure-26: United States - Forecast for In-Vitro Diagnostics Market by Urinalysis (Million US$), 2019 - 2024
  • Figure-27: United States - In-Vitro Diagnostics Market by Molecular - Non Infectious (Million US$), 2013 - 2018
  • Figure-28: United States - Forecast for In-Vitro Diagnostics Market by Molecular - Non Infectious (Million US$), 2019 - 2024
  • Figure-29: United States - In-Vitro Diagnostics Market by Coagulation (Million US$), 2013 - 2018
  • Figure-30: United States - Forecast for In-Vitro Diagnostics Market by Coagulation (Million US$), 2019 - 2024
  • Figure-31: United States - In-Vitro Diagnostics Market by Histology (Million US$), 2013 - 2018
  • Figure-32: United States - Forecast for In-Vitro Diagnostics Market by Histology (Million US$), 2019 - 2024
  • Figure-33: United States - In-Vitro Diagnostics Market by Hematology (Million US$), 2013 - 2018
  • Figure-34: Forecast for Online Food Delivery Market By Hematology (Million US$), 2019 - 2025
  • Figure-35: United States - In-Vitro Diagnostics Market by Blood Testing and Typing (Million US$), 2013 - 2018
  • Figure-36: United States - Forecast for In-Vitro Diagnostics Market by Blood Testing and Typing (Million US$), 2019 - 2024
  • Figure-37: United States - In-Vitro Diagnostics Market by Flow Cytometry (Million US$), 2013 - 2018
  • Figure-38: United States - Forecast for In-Vitro Diagnostics Market by Flow Cytometry (Million US$), 2019 - 2024
  • Figure-39: United States In-Vitro Diagnostics Products Market by Services (Million US$), 2013 - 2018
  • Figure-40: United States - Forecast for In-Vitro Diagnostics Products Market by Services (Million US$), 2019 - 2024
  • Figure-41: United States In-Vitro Diagnostics Products Market by Software (Million US$), 2013 - 2018
  • Figure-42: United States - Forecast for In-Vitro Diagnostics Products Market by Software (Million US$), 2019 - 2024
  • Figure-43: United States In-Vitro Diagnostics Products Market by Reagents (Million US$), 2013 - 2018
  • Figure-44: United States - Forecast for In-Vitro Diagnostics Products Market by Reagents (Million US$), 2019 - 2024
  • Figure-45: United States In-Vitro Diagnostics Products Market by Instruments (Million US$), 2013 - 2018
  • Figure-46: United States - Forecast for In-Vitro Diagnostics Products Market by Instruments (Million US$), 2019 - 2024
  • Figure-47: United States In-Vitro Diagnostics Market by South Regions (Million US$), 2013 - 2018
  • Figure-48: United States - Forecast for In-Vitro Diagnostics Market by South Regions (Million US$), 2019 - 2024
  • Figure-49: United States In-Vitro Diagnostics Market by West Regions (Million US$), 2013 - 2018
  • Figure-50: United States - Forecast for In-Vitro Diagnostics Market by West Regions (Million US$), 2019 - 2024
  • Figure-51: United States In-Vitro Diagnostics Market by Midwest Regions (Million US$), 2013 - 2018
  • Figure-52: United States - Forecast for In-Vitro Diagnostics Market by Midwest Regions (Million US$), 2019 - 2024
  • Figure-53: United States In-Vitro Diagnostics Market by North East Regions (Million US$), 2013 - 2018
  • Figure-54: United States - Forecast for In-Vitro Diagnostics Market by North East Regions (Million US$), 2019 - 2024
  • Figure-55: Prevalence of Chronic Disease in United States (1995 - 2030)
  • Figure-56: Global - Population aged 65 & Over, (in Millions), 2015, 2030 & 2050
  • Figure-57: Roche Diagnostics - Global Sales (Million US$), 2014 - 2018
  • Figure-58: Roche Diagnostics - Global Sales Forecast (Million US$), 2019 - 2024
  • Figure-59: Abbott Diagnostics - Global Sales (Million US$), 2014 - 2018
  • Figure-60: Abbott Diagnostics - Global Sales Forecast (Million US$), 2019 - 2024
  • Figure-61: Siemens Healthineers - Global Diagnostics Sales (Million US$), 2015 - 2018
  • Figure-62: Siemens Healthineers - Global Diagnostics Sales Forecast (Million US$), 2019 - 2024
  • Figure-63: Danaher Corporation - Global Diagnostics Sales (Million US$), 2014 - 2018
  • Figure-64: Danaher Corporation - Global Diagnostics Sales Forecast (Million US$), 2019 - 2024
  • Figure-65: Thermo Fisher Scientific - Global Diagnostics Sales (Million US$), 2014 - 2018
  • Figure-66: Thermo Fisher Scientific - Global Diagnostics Sales Forecast (Million US$), 2019 - 2024
  • Figure-67: Sysmex Corporation - Global Diagnostics Sales (Million US$), 2014 - 2018
  • Figure-68: Sysmex Corporation - Global Diagnostics Sales Forecast (Million US$), 2019 - 2024

In-vitro Diagnostics (IVD) serves a key role in the healthcare value chain by significantly influencing the quality of health outcomes, patient treatment, care and downstream resource requirements. In Vitro Diagnostics has proven itself to be the best diagnostic procedures in managing the chronic diseases. IVDs help in the early detection of patient's health condition and risk associated with it, creating new opportunities for the early intervention and prevention. United States In-Vitro Diagnostics (IVD) Market is the largest IVD market across the world and is also the leading consumer of the IVD market. IVD market increasingly is subject to demands for improved diagnosis and quality test results of patient's ailments. In Vitro Diagnostics help in responding such demands by enabling accurate detection of diseases and health risks at the earlier stages, aid in improved treatment and disease management, further diminishing the subsequent health risks and their associated cost. United States In Vitro Diagnostics (IVD) market is expected to be more than US$ 35 Billion by the end of year 2024.

In the United States, some of the common diagnostic tests conducted include cholesterol level tests, blood sugar tests, HIV tests, pap tests, tests for infectious diseases, hCG (pregnancy) tests and substance abuse tests. Some of the major factors stimulating the growth of the United States IVD market include a high incidence of chronic diseases, increasing preference for Point of Care (POC) diagnostics, technological advancements in the field of diagnostics and increasing awareness and acceptance regarding personalized medicine. In addition; government favorable healthcare policy, better healthcare infrastructure and increasing consumer's healthcare expenditure for seeking quality healthcare further helps United States IVD Market to grow effortlessly over the forecast period.

Renub Research report titled "United States In Vitro Diagnostics Market, IVD Segments (Clinical Chemistry, Microbiology -ID/AST, Microbiology - Molecular, POC - Professional, POC - OTC Diabetes, POC - Others, Immunoassay - Infectious, Immunoassay - Others, Urinalysis, Molecular - Non Infectious, Coagulation, Histology, Hematology, Blood Testing and Typing, Flow Cytometry), Products (Services, Software, Reagents, Instruments) Regions (South, West, Midwest, North East), Companies (Roche Diagnostics, Abbott Diagnostics, Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific, Sysmex Corporation)" provides a complete analysis of United States In Vitro Diagnostics (IVD) Market.

Point of Care Testing market dominates United States In-Vitro Diagnostics (IVD) Market

United States In Vitro Diagnostics (IVD) Market is segmented into Clinical chemistry, Microbiology -ID/AST, Microbiology - Molecular, POC - Professional, POC - OTC Diabetes, POC - Others, Immunoassay - Infectious, Immunoassay - Others, Urinalysis, Molecular - Non Infectious, Coagulation, Histology, Hematology, Blood Testing and Typing, Flow Cytometry. Point of care testing market dominates the United States In-Vitro Diagnostics (IVD) market.

Instruments and Reagents are leading Products in the United States In-Vitro Diagnostics (IVD) Market

On the basis of products, United States In-Vitro Diagnostics (IVD) market is segmented into service, software, instruments and reagents. Instruments and reagents are top two leading products in the United States In-Vitro Diagnostics (IVD) market.

South Region holds impressive share in the United States In-Vitro Diagnostics (IVD) Market

In this report, we have categorized the United States In-Vitro Diagnostics (IVD) market into four regions; South, West, Midwest, North East. It is anticipated that South and West regions plays the significant role in the United States In-Vitro Diagnostics (IVD) market during the forecast period of 2019-2024.

Company Analysis

Roche Diagnostics, Abbott Diagnostics, Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific, Sysmex Corporation are some of the top companies operating in the In-Vitro Diagnostics segment globally. All the companies have been studied from three points:

  • Overview
  • Initiatives & Recent Developments
  • Sales

By Segments - United States In-Vitro Diagnostics (IVD) Market:

  • 1. Clinical chemistry
  • 2. Microbiology -ID/AST
  • 3. Microbiology - Molecular
  • 4. POC - Professional
  • 5. POC - OTC Diabetes
  • 6. POC - Others
  • 7. Immunoassay - Infectious
  • 8. Immunoassay - Others
  • 9. Urinalysis
  • 10. Molecular - Non Infectious
  • 11. Coagulation
  • 12. Histology
  • 13. Hematology
  • 14. Blood Testing and Typing
  • 15. Flow Cytometry

By Products - United States In-Vitro Diagnostics (IVD) Market:

  • Services
  • Software
  • Reagents
  • Instruments

By Regions - United States In-Vitro Diagnostics (IVD) Market:

  • South
  • West
  • Midwest
  • North East

Company covered in this report:

  • Roche Diagnostics
  • Abbott Diagnostics
  • Siemens Healthineers
  • Danaher Corporation
  • Thermo Fisher Scientific
  • Sysmex Corporation

Table of Contents

1.. Introduction

2.. Research & Methodology

3.. United States In-Vitro Diagnostics (IVD) Market

4.. Market Share - United States In-Vitro Diagnostics (IVD) Analysis

  • 4.1. By Segments
  • 4.2. By Products
  • 4.3. By Regions

5.. Segments - United States In-Vitro Diagnostics (IVD) Market

  • 5.1. Clinical Chemistry
  • 5.2. Microbiology -ID/AST
  • 5.3. Microbiology - Molecular
  • 5.4. POC - Professional
  • 5.5. POC - OTC Diabetes
  • 5.6. POC - Others
  • 5.7. Immunoassay - Infectious
  • 5.8. Immunoassay - Others
  • 5.9. Urinalysis
  • 5.10. Molecular - Non Infectious
  • 5.11. Coagulation
  • 5.12. Histology
  • 5.13. Hematology
  • 5.14. Blood Testing and Typing
  • 5.15. Flow Cytometry

6.. Products - United States In-Vitro Diagnostics (IVD) Market

  • 6.1. Services
  • 6.2. Software
  • 6.3. Reagents
  • 6.4. Instruments

7.. Regions - United States In-Vitro Diagnostics (IVD) Market

  • 7.1. South
  • 7.2. West
  • 7.3. Midwest
  • 7.4. North East

8.. Market Dynamics

  • 8.1. Growth Drivers
    • 8.1.1. Growth in Chronic & Infectious Disease
    • 8.1.2. Technological Advances
    • 8.1.3. Aging Population
  • 8.2. Challenges
    • 8.2.1. Cumbersome Reimbursement Procedure
    • 8.2.2. Shortage of Lab Technicians

9.. Company Analysis

  • 9.1. Roche Diagnostics
    • 9.1.1. Overview
    • 9.1.2. Initiatives & Recent Developments
    • 9.1.3. Sales
  • 9.2. Abbott Diagnostics
    • 9.2.1. Overview
    • 9.2.2. Initiatives & Recent Developments
    • 9.2.3. Sales
  • 9.3. Siemens Healthineers
    • 9.3.1. Overview
    • 9.3.2. Initiatives & Recent Developments
    • 9.3.3. Sales
  • 9.4. Danaher Corporation
    • 9.4.1. Overview
    • 9.4.2. Initiatives & Recent Developments
    • 9.4.3. Sales
  • 9.5. Thermo Fisher Scientific
    • 9.5.1. Overview
    • 9.5.2. Initiatives & Recent Developments
    • 9.5.3. Sales
  • 9.6. Sysmex Corporation
    • 9.6.1. Overview
    • 9.6.2. Initiatives & Recent Developments
    • 9.6.3. Sales
Back to Top
전화 문의
F A Q